Madrigal Investors Focus on Rezdiffra Growth at Goldman Event
CONSHOHOCKEN, PA — Madrigal Pharmaceuticals Inc. (NASDAQ: MDGL) is set to present at the Goldman Sachs Global Healthcare Conference this week as investors evaluate the commercial trajectory of Rezdiffra, the …
Madrigal Investors Focus on Rezdiffra Growth at Goldman Event Read More